3,4-dihydroxybenzohydroxamic acid has been researched along with 3,4,5-trihydroxybenzamidoxime in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Elford, HL; Novotny, L; Romanova, D; Szekeres, T; Vachalkova, A | 1 |
| Macáková, K; Miadoková, E; Podstavková, S; Vlcek, D | 1 |
| Birch, NJ; Elford, HL; Gallicchio, VS; Hughes, NK; Mayhew, C; Oakley, O; Phillips, J; Piper, J | 1 |
| Chitambar, CR; Elford, HL; Myette, MS | 1 |
| Birch, NJ; Elford, HL; Gallicchio, VS; Greenberg, RN; Mayhew, CN; Phillips, JD | 1 |
| Adunyah, SE; Asakura, T; Elford, HL; Fasold, H; Horiuchi, K; Iyamu, WE; Turner, EA | 1 |
| Smart, T | 1 |
| Ahmed, MM; Chendil, D; Elford, HL; Gallicchio, VS; Greenberg, RN; Mampuru, LJ; Mayhew, CN; Phillips, JD | 1 |
| Cibull, ML; Elford, HL; Gallicchio, VS; Mayhew, CN; Phillips, JD | 1 |
| Chou, TC; Dong, HJ; Figul, M; Rainov, NG; Söling, A | 1 |
| Duvall, W; Elford, HL; Gallicchio, VS; Hagan, E; Inayat, MS; Mayhew, CN; Sumpter, LR; Yost, EE | 1 |
| Cibull, M; Elford, HL; Gallicchio, VS; Inayat, M; Mayhew, CN; Phillips, JD; Sumpter, R | 1 |
| Belcher, J; Hebbel, RP; Kaul, DK; Kelm, RJ; Kollander, R; Liu, XD; Mahaseth, H; Solovey, A; Vercellotti, GM | 1 |
| Bhave, S; Elford, H; McVoy, MA | 1 |
17 other study(ies) available for 3,4-dihydroxybenzohydroxamic acid and 3,4,5-trihydroxybenzamidoxime
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The new inhibitors of ribonucleotide reductase--comparison of some physico-chemical properties.
Topics: Benzamidines; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Hydrogen-Ion Concentration; Hydroxamic Acids; Oximes; Polarography; Ribonucleotide Reductases; Spectrophotometry, Ultraviolet | 1997 |
Genotoxic properties of the newly synthesized antineoplastic agents amidox, didox and trimidox.
Topics: Animals; Antineoplastic Agents; Benzamidines; Enzyme Inhibitors; Frameshift Mutation; Hydroxamic Acids; In Vitro Techniques; Mutagenicity Tests; Mutagens; Oximes; Rats; Ribonucleotide Reductases; Salmonella typhimurium; Subcellular Fractions | 1997 |
Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
Topics: Animals; Antiviral Agents; Benzamidines; Biomarkers; Didanosine; Disease Progression; Drug Therapy, Combination; Female; Hydroxamic Acids; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Ribonucleotide Reductases; Survival Rate | 1997 |
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Topics: Antineoplastic Agents; Benzamidines; Cell Division; Deoxycytidine; Drug Synergism; Enzyme Inhibitors; Gallium; Gemcitabine; Humans; Hydroxamic Acids; Hydroxyurea; Oximes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured | 1998 |
Protease inhibitors and subtypes.
Topics: Benzamidines; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxamic Acids; Serotyping; Treatment Outcome | 1999 |
Drug targets cellular enzyme.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Benzamidines; Disease Models, Animal; Drug Resistance, Microbial; Humans; Hydroxamic Acids; Immunity, Cellular; Mice; Ribonucleotide Reductases; Sensitivity and Specificity | 1999 |
In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Anti-HIV Agents; Benzamidines; Cells, Cultured; Colony-Forming Units Assay; Enzyme Inhibitors; Female; Femur; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hydroxamic Acids; Hydroxyurea; In Vitro Techniques; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Organ Size; Ribonucleotide Reductases; Spleen | 1999 |
Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
Topics: Antineoplastic Agents; Benzamidines; Cell Differentiation; Cell Division; Drug Therapy, Combination; Enzyme Inhibitors; Fetal Hemoglobin; Hemoglobin, Sickle; Humans; Hydroxamic Acids; K562 Cells; Ribonucleotide Reductases; Streptozocin | 2000 |
Beyond hydroxyurea.
Topics: Animals; Antiviral Agents; Benzamidines; Dipyridamole; Disease Models, Animal; Floxuridine; Fluorouracil; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Murine Acquired Immunodeficiency Syndrome; Ribonucleotide Reductases | 1995 |
Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
Topics: Animals; Benzamidines; Bone Marrow Cells; DNA, Viral; Female; Femur; Free Radical Scavengers; Hematopoietic Stem Cells; Hydroxamic Acids; Hydroxyurea; Hypergammaglobulinemia; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Proviruses; Retroviridae Infections; Ribonucleotide Reductases; Spleen; Splenomegaly; Tumor Virus Infections | 2002 |
Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea.
Topics: Animals; Antiviral Agents; Benzamidines; Blood Cell Count; Body Weight; Bone Marrow; Hydroxamic Acids; Hydroxyurea; Leukemia Virus, Murine; Lymphoproliferative Disorders; Mice; Spleen; Time Factors | 2002 |
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.
Topics: Antineoplastic Agents, Alkylating; Benzamidines; Brain Neoplasms; Dacarbazine; Drug Synergism; Enzyme Inhibitors; Glioma; Humans; Hydroxamic Acids; Ribonucleotide Reductases; Temozolomide; Tumor Cells, Cultured | 2003 |
In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease.
Topics: Animals; Antiviral Agents; Benzamidines; Bone Marrow Cells; Dideoxynucleosides; Disease Models, Animal; Drug Therapy, Combination; Hematopoietic Stem Cells; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Ribonucleotide Reductases; Spleen; Splenomegaly | 2004 |
Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Topics: Animals; Antiviral Agents; B-Lymphocytes; Benzamidines; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hydroxamic Acids; Hydroxyurea; Leukemia Virus, Murine; Leukemia, Experimental; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribonucleotide Reductases; Treatment Outcome; Tumor Virus Infections | 2005 |
Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation.
Topics: Anemia, Sickle Cell; Animals; Benzamidines; Blood Coagulation; Cell Communication; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelial Cells; Enzyme Inhibitors; Humans; Hydroxamic Acids; Inflammation; Leukocytes; Mice; Mice, Transgenic; Thromboplastin | 2006 |
Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
Topics: Antiviral Agents; Benzamidines; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Synergism; Ganciclovir; Humans; Hydroxamic Acids; Hydroxyurea; Inhibitory Concentration 50; Ribonucleotide Reductases | 2013 |